Premier, Inc.
NASDAQ•PINC
CEO: Mr. Michael J. Alkire
セクター: Healthcare
業種: Medical - Healthcare Information Services
上場日: 2013-09-26
Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services for coordinate purchasing decisions, review utilization and achieve and maintain standardization across member's facilities; SaaS informatics products for the purchase additional elements; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is headquartered in Charlotte, North Carolina.
連絡先情報
時価総額
$2.34B
PER (TTM)
-97.3
37.7
配当利回り
1.5%
52週高値
$28.79
52週安値
$17.23
52週レンジ
順位29Top 17.8%
5.2
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
堅調 • 5.2 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025
財務ダッシュボード
Q1 2026 データ
売上高
$240.00M-3.28%
直近4四半期の推移
EPS
$0.21-70.42%
直近4四半期の推移
フリーCF
-$3.57M-107.16%
直近4四半期の推移
2026 Q1 決算ハイライト
主なハイライト
Merger Agreement Signed Acquisition by Patient Square affiliate agreed for $28.25 cash per share, subject to closing conditions.
IllumiCare Acquisition Complete Preliminary $46.7M purchase price paid for IllumiCare, boosting Performance Services segment operations.
Adjusted EBITDA Declines Total Adjusted EBITDA $54.95M for the quarter, a decrease of $7.48M versus prior year results.
リスク要因
Merger Closing Contingencies Merger completion relies on stockholder vote and regulatory approvals; timing and success remain uncertain.
Performance Services EBITDA Drop Performance Services Segment Adjusted EBITDA fell 29% to $10.62M due to enterprise license revenue decline.
Operating Cash Flow Weakness Operating cash flow from continuing operations $15.93M, down $64.1M from prior period results.
見通し
Contigo Business Wind Down Remaining Contigo Health businesses expected to be substantially wound down by December 31, 2025.
GPO Contract Renewal Focus Expect majority of remaining GPO member agreement renewals to be addressed during fiscal year 2026.
Future Intangible Amortization Estimated total amortization expense for intangible assets is $237.69M over the next several fiscal years.
同業比較
売上高 (TTM)
$10.31B
$3.68B
$3.31B
粗利益率 (最新四半期)
101.2%
96.9%
86.6%
主要指標
銘柄コード | 時価総額 | PER (TTM) | ROE (TTM) | 負債比率 |
|---|---|---|---|---|
| DNLI | $3.43B | -7.4 | -50.1% | 3.7% |
| DYN | $3.30B | -5.8 | -61.5% | 1.7% |
| ITGR | $2.99B | 29.0 | 6.0% | 41.0% |
長期トレンド
直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
-0.0%
横ばい
4四半期純利益CAGR
N/M
収益構造の変化
キャッシュフロー安定性
100%
優れたキャッシュフローの実績
深度リサーチ
次回決算:2026年5月4日
EPS:-
|売上高:-
財務データ
決算説明会
財務レポート
ニュース
損益計算書
バランスシート
キャッシュフロー計算書
財務比率
変化率
損益計算書 | 直近12ヶ月 |
|---|
データなし